Patrick Trucchio
Stock Analyst
(n/a)
# 1,636
Out of 4,641 analysts
278
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $31.98 | +212.70% | 16 | Oct 24, 2024 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $5 | $1.51 | +231.15% | 17 | Oct 23, 2024 | |
| ALNY Alnylam Pharmaceuticals | Reiterates: Buy | $400 | $293.97 | +36.07% | 20 | Oct 18, 2024 | |
| LBPH Longboard Pharmaceuticals | Downgrades: Neutral | $80 → $60 | $59.55 | +0.76% | 14 | Oct 15, 2024 | |
| MIST Milestone Pharmaceuticals | Reiterates: Buy | $25 | $1.43 | +1,654.39% | 14 | Oct 14, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Reiterates: Buy | $60 | $19.82 | +202.72% | 17 | Oct 11, 2024 | |
| ONCY Oncolytics Biotech | Reiterates: Buy | $5 | $1.22 | +309.63% | 14 | Sep 19, 2024 | |
| GOSS Gossamer Bio | Reiterates: Buy | $10 | $0.90 | +1,012.97% | 13 | Sep 17, 2024 | |
| GHRS GH Research | Reiterates: Buy | $40 | $7.73 | +417.80% | 10 | Sep 5, 2024 | |
| IVVD Invivyd | Reiterates: Buy | $15 | $0.96 | +1,460.39% | 12 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.16 | +1,193.10% | 13 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $18.15 | +313.34% | 17 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $55 | $6.13 | +797.96% | 15 | Aug 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $6.39 | +1,777.93% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $10.62 | -52.92% | 13 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $6.72 | +78.70% | 11 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $8.52 | +604.23% | 13 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $21.86 | +265.97% | 2 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $6.55 | +358.02% | 4 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $6.42 | +289.41% | 9 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $7.36 | +1,394.57% | 18 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $10.83 | +527.89% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $230 → $20 | $1.20 | +1,573.64% | 2 | Dec 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $293.17 | +15.97% | 1 | Aug 18, 2021 |
Immunocore Holdings
Oct 24, 2024
Reiterates: Buy
Price Target: $100
Current: $31.98
Upside: +212.70%
Sangamo Therapeutics
Oct 23, 2024
Reiterates: Buy
Price Target: $5
Current: $1.51
Upside: +231.15%
Alnylam Pharmaceuticals
Oct 18, 2024
Reiterates: Buy
Price Target: $400
Current: $293.97
Upside: +36.07%
Longboard Pharmaceuticals
Oct 15, 2024
Downgrades: Neutral
Price Target: $80 → $60
Current: $59.55
Upside: +0.76%
Milestone Pharmaceuticals
Oct 14, 2024
Reiterates: Buy
Price Target: $25
Current: $1.43
Upside: +1,654.39%
Arrowhead Pharmaceuticals
Oct 11, 2024
Reiterates: Buy
Price Target: $60
Current: $19.82
Upside: +202.72%
Oncolytics Biotech
Sep 19, 2024
Reiterates: Buy
Price Target: $5
Current: $1.22
Upside: +309.63%
Gossamer Bio
Sep 17, 2024
Reiterates: Buy
Price Target: $10
Current: $0.90
Upside: +1,012.97%
GH Research
Sep 5, 2024
Reiterates: Buy
Price Target: $40
Current: $7.73
Upside: +417.80%
Invivyd
Sep 3, 2024
Reiterates: Buy
Price Target: $15
Current: $0.96
Upside: +1,460.39%
Aug 30, 2024
Reiterates: Buy
Price Target: $15
Current: $1.16
Upside: +1,193.10%
Aug 30, 2024
Reiterates: Buy
Price Target: $75
Current: $18.15
Upside: +313.34%
Aug 29, 2024
Maintains: Buy
Price Target: $35 → $55
Current: $6.13
Upside: +797.96%
Aug 23, 2024
Reiterates: Buy
Price Target: $120
Current: $6.39
Upside: +1,777.93%
Aug 23, 2024
Reiterates: Buy
Price Target: $5
Current: $10.62
Upside: -52.92%
Aug 22, 2024
Reiterates: Buy
Price Target: $12
Current: $6.72
Upside: +78.70%
Aug 22, 2024
Reiterates: Buy
Price Target: $60
Current: $8.52
Upside: +604.23%
Aug 22, 2024
Reiterates: Buy
Price Target: $80
Current: $21.86
Upside: +265.97%
Aug 20, 2024
Reiterates: Buy
Price Target: $30
Current: $6.55
Upside: +358.02%
Aug 20, 2024
Reiterates: Buy
Price Target: $25
Current: $6.42
Upside: +289.41%
Aug 20, 2024
Reiterates: Buy
Price Target: $110
Current: $7.36
Upside: +1,394.57%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $10.83
Upside: +527.89%
Dec 28, 2021
Maintains: Buy
Price Target: $230 → $20
Current: $1.20
Upside: +1,573.64%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $293.17
Upside: +15.97%